INVETX
Invetx is a veterinary therapeutics company that focuses on biopharmaceuticals that bring human biotechnology to animal health. Invetx is building the world’s premier animal health biotechnology innovation platform for protein-based therapeutics. Working closely with best-in-class biotechnology companies, major investors and an extensive network of industry experts, Invetx is focused on guiding the development of an exciting portfolio of therapies and technologies to deliver the future of an... imal care. Invetx's network includes experts in both animal and human health, veterinary scientists and clinicians. The company's vision is of a global animal health industry that fully leverages biopharma technologies to deliver dramatically improved health outcomes for pets and farm animal populations.
INVETX
Industry:
Biopharma Biotechnology Veterinary
Founded:
2018-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.invetx.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
85.75 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Wordpress Plugins
Similar Organizations
Sagimet Biosciences
Sagimet Biosciences is a biotechnology company that focuses on developing novel therapeutics to treat important diseases.
Demetrix
Demetrix is a biotechnology company dedicated to researching and producing bioactive ingredients.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Kindred Biosciences
Kindred Biosciences is a veterinary biotechnology company that focuses on developing therapies for dogs, cats and horses.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Eight Roads Ventures
Eight Roads Ventures investment in Series B - Invetx
Tekla Capital Management
Tekla Capital Management investment in Series B - Invetx
F-Prime Capital
F-Prime Capital investment in Series B - Invetx
Novo Holdings
Novo Holdings investment in Series B - Invetx
Anterra Capital
Anterra Capital investment in Series B - Invetx
GV
GV investment in Series B - Invetx
Casdin Capital
Casdin Capital investment in Series B - Invetx
AbCellera Biologics
AbCellera Biologics investment in Series A - Invetx
Anterra Capital
Anterra Capital investment in Series A - Invetx
WuXi Biologics
WuXi Biologics investment in Series A - Invetx
Key Employee Changes
| Date | New article |
|---|---|
| 2020-09-30 | Invetx Appoints Bill Brondyk, Colin Giles to Executive Team |
Official Site Inspections
http://www.invetx.com Semrush global rank: 1.78 M Semrush visits lastest month: 13.01 K
- Host name: 95.70.73.34.bc.googleusercontent.com
- IP address: 34.73.70.95
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Invetx"
Invetx - Crunchbase Company Profile & Funding
Invetx is a veterinary therapeutics company that develops protein-based therapeutics for animal health. Invetx's network includes animal and human health experts, veterinary scientists, and clinicians. The company's vision is of a …See details»
Invetx - LinkedIn
We are thrilled to announce that Invetx has agreed to be acquired by Dechra Pharmaceuticals, a global leader in animal health, for up to $520 million on a cash-free and debt-free basis.See details»
Dechra Announces Acquisition of Invetx
Jul 18, 2024 Invetx is a pioneer in creating novel, protein-based animal health therapeutics to transform standards of care in veterinary medicine. The company leverages a best-in-class, …See details»
Invetx - Funding, Financials, Valuation & Investors - Crunchbase
Invetx is a veterinary therapeutics company that develops protein-based therapeutics for the treatment of various animal diseases. Search Crunchbase. ... How much funding has this …See details»
Invetx Company Profile 2025: Valuation, Investors, Acquisition
Invetx General Information Description. Developer of a biotechnology innovation platform designed to build protein-based therapeutics. The company's platform uses deep expertise …See details»
Invetx - The Org
At Invetx, they bring the best of biopharma to animal health. Their network includes experts in both animal and human health, veterinary scientists, and clinicians. Their vision is of a global …See details»
News & Press Releases - Invetx - Biopharma for Animal Health
Jun 26, 2023 Boston, MA, November 29, 2023 – Invetx, a pioneer in protein-based therapeutics for animal health, announced results of a market research study showing that both …See details»
Absci and Invetx Partner to Bring Generative AI Drug
6 days ago Invetx was acquired by Dechra Pharmaceuticals Limited, a global specialist veterinary pharmaceuticals business, in July 2024. Invetx is headquartered in Boston, …See details»
Invetx Acquisition - Dechra
Invetx is a pioneer in creating novel, protein-based animal health therapeutics to transform standards of care in veterinary medicine. The company leverages a best-in-class, fully …See details»
Invetx, Inc. Company Profile | Natick, MA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Invetx, Inc. of Natick, MA. Get the latest business insights from Dun & Bradstreet.See details»
Invetx Company Profile - Office Locations, Competitors, Revenue
Invetx is a veterinary therapeutics company that focuses on biopharmaceuticals. It creates an animal health biotechnology platform for protein-based therapeutics. The company benefits …See details»
Invetx - VentureRadar
Invetx is building the world’s premier biotechnology platform for protein-based therapeutics in animal health to transform standards of care in veterinary medicine. The company has …See details»
Invetx - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Invetx . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. ... Invetx has 1 board …See details»
Invetx - Updates, News, Events, Signals & Triggers - Crunchbase
Invetx may be growing as it has been identified as a notable investment by venture partners, indicating investor confidence and potential financial backing. The company's market research …See details»
Invetx Announces Completion of $25.5 Million Series A Financing …
Sep 30, 2020 Invetx Announces Upcoming Acquisition by Dechra Pharmaceuticals, Global Leader in Animal Health. Boston, MA, November 29, 2023 – Invetx, a pioneer in protein-based …See details»
Invetx Announces $15 Million Series A Financing and Industry …
Feb 24, 2020 Invetx Announces Upcoming Acquisition by Dechra Pharmaceuticals, Global Leader in Animal Health. Boston, MA, November 29, 2023 – Invetx, a pioneer in protein-based …See details»
Absci and Invetx Partner to Bring Generative AI Drug Creation …
6 days ago About Invetx Invetx is a pioneer in creating novel, protein-based animal health therapeutics to transform standards of care in veterinary medicine. The company leverages a …See details»
Invetx Announces Industry-Leading Antibody Discovery Platform …
Jul 16, 2020 Invetx Announces Upcoming Acquisition by Dechra Pharmaceuticals, Global Leader in Animal Health. Boston, MA, November 29, 2023 – Invetx, a pioneer in protein-based …See details»
Boehringer Ingelheim and Invetx Announce Strategic …
Sep 27, 2021 About Invetx Invetx is building the world’s premier biotechnology platform for protein-based therapeutics in animal health to transform standards of care in veterinary …See details»
AbCellera and Invetx Expand Multi-Year Antibody Discovery …
Nov 19, 2020 Invetx’s Market Research Study Reveals Nearly 40% of Dogs in the U.S. Suffer from Chronic Osteoarthritis/Pain. Boston, MA, November 29, 2023 – Invetx, a pioneer in …See details»